Prophylactic or therapeutic agent for amnesia
US6281242A · kind A · utility
13Cited by
5References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 2, 2000 |
| Grant date | Aug 28, 2001 |
| Priority date | — |
| Expiry date | Jun 2, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A medicament comprising as an active ingredient a compound represented by the following formula: R.sup.2 --CH.sub.2 CONH--R.sup.1 wherein R.sup.1 represents pyridyl group, a substituted pyridyl group, phenyl group, or a substituted phenyl group; and R.sup.2 represents a 2-oxo-1-phyrrolidinyl group which may be substituted (e.g., N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl)acetamide), which is useful for preventive and/or therapeutic treatment of amnesia caused by, for example, an anesthetic agent for intravenous administration such as propofol.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.